Statement by Marc de Garidel on Abivax's 2024 Half-Year Financial Report

Marc de Garidel, CEO of Abivax, confirmed that the financial statements for the first half of 2024 are compliant with IFRS standards. He assured that these statements provide a true and fair view of the company's assets, financial position and results.

The half-yearly report, detailed on pages 6 to 14, presents a summary of the major events that marked the first six months of the year. It also includes the impacts of these events on the financial statements and highlights the main transactions between related parties.

Garidel also noted that the report outlines the risks and uncertainties that the company may encounter in the next six months. This approach aims to maintain full transparency with investors and stakeholders.